Our present findings show that Sclerostin is active and in high amounts at the initial stages of the disease when inflammation initiates osteoclastogenesis during gingivitis, while WNT-5a is osteoclastogenic and active during the chronic inflammatory process, which is associated with active bone destruction in periodontitis. Here, WNT5A is linked to gingivitis.